Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2020-02-24
2020-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pain Sensitivity During Puberty
NCT05145595
Pain Prevalence in Hospitalized Patients
NCT04901650
Enhancing Analgesia in Chronic Pain Through Exercise
NCT04862871
Pain Sensitivity and Psychological Profile of Chronic Low Back Pain Patients
NCT04879394
Skin Conductance Fluctuations Per Sec and NRS to Monitor Pain
NCT01865344
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Asthmatic patients
No interventions assigned to this group
Allergic patients
No interventions assigned to this group
Control group
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Accepted to sign the informed consent.
* Diagnosis of asthma or allergy.
Exclusion Criteria
* Orthopedic pathologies limiting test performance.
* Active smokers.
* Neurologic pathologies limiting voluntary mobility.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Granada
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marie Carmen Valenza
Marie Carmen Valenza
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DF0090UG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.